GSK Sues Pfizer, BioNTech for Share of Billions in Vaccine Sales

GlaxoSmithKline filed a federal lawsuit seeking to recoup a share of the tens of billions of dollars in revenue Pfizer and BioNTech have reported from sales of their Covid-19 vaccines, which GSK alleges infringe five patents related to mRNA vaccine technology.

The complaint relates to patents discovered by researchers who began working on mRNA vaccines in 2008, the rights to which GSK later acquired. The mRNA vaccines that were later produced by Pfizer and BioNTech for Covid have continued to generate billions in revenue for the two companies for years after their initial release.

Two GSK units—GlaxoSmithKline Biologicals SA and ...